Award
National Cancer Institute 1R01CA316572-01
HSP70 as an actionable cancer-specific target
Recipient
Medical University of South Carolina
Award Amount
$531,584.00
Ceiling
$531,584.00
Awarded
July 30, 2026
Identifier
1R01CA316572-01
Research grant awarded by the National Cancer Institute to the Medical University of South Carolina for studying HSP70 as a cancer-specific target in pancreatic cancer, with a focus on drug discovery and cancer immunology.
Description
This is a research grant opportunity from the National Cancer Institute for a project on HSP70 as a therapeutic target in pancreatic cancer (PDAC). The project involves in vivo models, drug discovery, and cancer immunology. The project aims to investigate tumor cell-intrinsic mechanisms and immune microenvironment remodeling related to HSP70 inhibition.